The I-SPY 2 Trial is an innovative clinical trial specifically designed to accelerate the process of identifying effective treatments for high-risk breast cancer. The trial employs an adaptive design to test multiple therapies simultaneously, aiming to match patients with the most promising drugs based on their tumor biology.
